[PubMed] [Google Scholar] 86.Speakman J.R., de Jong J.M.A., Sinha S., Westerterp K.R., Yamada Y., Sagayama H., Ainslie P.N., Anderson L.J., Arab L., Bedu-Addo K., et al
LEADER 5: prevalence and cardiometabolic impact of obesity in cardiovascular high-risk patients with type 2 diabetes mellitus: baseline global data from the LEADER trial
Managing side effects (if there are any) Calorie deficit diet and more physical activity Regular check-ups with your healthcare provider are necessary to monitor your progress and adjust dosages
Important Note on the Evidence Base Important note on the evidence base: The Epithalon research literature has several characteristics that buyers should understand clearly
Mol Cell Endocrinol 2001
Digestive comfort depends more on food composition than sugar content alone